Barrowclough, C, Haddock, G, Wykes, T, Beardmore, R, Conrod, P, Craig, T, Davies, L, Dunn, G, Eisner, E, Lewis, S, Moring, J, Steel, C, Tarrier, N (2010). Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial. British Medical Journal 341, c6325.
Bentall, RP, Wickham, S, Shevlin, M, Varese, F (2012). Do specific early-life adversities lead to specific symptoms of psychosis? A study from the 2007 the adult psychiatric morbidity survey. Schizophrenia Bulletin 38, 734–740.
Blaj, A (2007). Bleuler's disease? Re: renaming schizophrenia: the need for evidence. British Medical Journal, Rapid Response.
Braff, DL, Ryan, J, Rissling, AJ, Carpenter, WT (2013). Lack of use in the literature from the last 20 years supports dropping traditional schizophrenia subtypes from DSM-5 and ICD-11. Schizophrenia Bulletin 39, 751–753.
Cunningham Owens, DG, Carroll, A, Fattah, S, Clyde, Z, Coffey, I, Johnstone, EC (2001). A randomized, controlled trial of a brief interventional package for schizophrenic out-patients. Acta Psychiatrica Scandinavica 103, 362–369.
Cuthbert, BN, Insel, TR (2013). Toward the future of psychiatric diagnosis: the seven pillars of RDoC. BMC Medicine 11, 126.
Desapriya, E, Nobutada, I (2003). Debate over Japanese renaming of term for schizophrenia. Lancet 361, 181.
Dudley, R, Siitarinen, J, James, I, Dodgson, G (2009). What do people with psychosis think caused their psychosis? A Q methodology study. Behavioural and Cognitive Psychotherapy 37, 11–24.
George, B (2009). Salience dysregulation syndrome: a patient's view. British Journal of Psychiatry 194, 467.
Green, AI, Drake, RE, Brunette, MF, Noordsy, DL (2007). Schizophrenia and co-occurring substance use disorder. American Journal of Psychiatry 164, 402–408.
Kim, Y (2002). Renaming the term schizophrenia in Japan. Lancet 360, 879.
Kingdon, D (2007). Down with schizophrenia. New Scientist 2625, 35–53.
Kingdon, D, Turkington, D (2005). Cognitive Therapy for Schizophrenia. Guilford: New York.
Kingdon, D, Vincent, S, Kinoshita, Y, Turkington, D (2008). Destigmatising schizophrenia: does changing terminology reduce negative attitudes? Psychiatric Bulletin 32, 419–422.
Kingdon, DG, Kinoshita, Y, Naeem, F, Swelam, M, Hansen, L, Vincent, S, Rathod, S (2007). Schizophrenia can and should be renamed. British Medical Journal 334, 221–222.
Kingdon, DG, Ashcroft, K, Bhandari, B, Gleeson, S, Warikoo, N, Symons, M, Taylor, L, Lucas, E, Mahendra, R, Ghosh, S, Mason, A, Badrakalimuthu, R, Hepworth, C, Read, J, Mehta, R (2010). Schizophrenia and borderline personality disorder: similarities and differences in the experience of auditory hallucinations, paranoia, and childhood trauma. Journal of Nervous and Mental Diseases 198, 399–403.
Kinoshita, Y, Kingdon, D, Kinoshita, K, Sarafudheen, S, Umadi, D, Dayson, D, Hansen, L, Rathod, S, Ibbotson, RB, Turkington, D, Furukawa, TA (2012). A semi-structured clinical interview for psychosis sub-groups (SCIPS): development and psychometric properties. Social Psychiatry and Psychiatric Epidemiology 47, 563–580.
Lieberman, JA, First, MB (2007). Renaming schizophrenia. British Medical Journal 334, 108.
Manrique-Garcia, E, Zammit, S, Dalman, C, Hemmingsson, T, Andreasson, S, Allebeck, P (2012). Cannabis, schizophrenia and other non-affective psychoses: 35 years of follow-up of a population-based cohort. Psychological Medicine 42, 1321–1328.
Mansell, W, Morrison, A (2007). Trauma and Psychosis. Psychology Press: London.
Miles, H, Johnson, S, Amponsah-Afuwape, S, Finch, E, Leese, M, Thornicroft, G (2003). Characteristics of subgroups of individuals with psychotic illness and a comorbid substance use disorder. Psychiatric Services 54, 554–561.
Myin-Germeys, I, Delespaul, P, Van Os, J (2005). Behavioural sensitization to daily life stress in psychosis. Psychological Medicine 35, 733–741.
Naeem, F, Kingdon, D, Turkington, D (2005). Cognitive behavior therapy for schizophrenia in patients with mild to moderate substance misuse problems. Cognitive Behavioral Therapy 34, 207–215.
Rathod, S, Kingdon, DG, Smith, P, Turkington, D (2005). Insight into schizophrenia: the effects of cognitive behavioural therapy on the components of insight and association with sociodemographics – data on a previously published randomised controlled trial. Schizophrenia Research 5, 211–219.
Sato, M (2006). Renaming schizophrenia: a Japanese perspective. World Psychiatry 5, 53–55.
Takahashi, H, Ideno, T, Okubo, S, Matsui, H, Takemura, K, Matsuura, M, Kato, M, Okubo, Y (2009). Impact of changing the Japanese term for ‘schizophrenia’ for reasons of stereotypical beliefs of schizophrenia in Japanese youth. Schizophrenia Research 112, 149–152.
Tomiyama, G (1990). Chronic schizophrenia-like states in methamphetamine psychosis. Japanese Journal of Psychiatry and Neurology 44, 531–9.
Van Os, J (2009 a). A salience dysregulation syndrome. British Journal of Psychiatry 194, 101–103.
Van Os, J (2009 b). ‘Salience syndrome’ replaces ‘schizophrenia’ in DSM-V and ICD-11: psychiatry's evidence-based entry into the 21st century? Acta Psychiatrica Scandinavica 120, 363–372.